312 related articles for article (PubMed ID: 34060699)
1. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
Ding Y; Labitzky V; Legler K; Qi M; Schumacher U; Schmalfeldt B; Stürken C; Oliveira-Ferrer L
Mol Oncol; 2021 Dec; 15(12):3578-3595. PubMed ID: 34060699
[TBL] [Abstract][Full Text] [Related]
2. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion.
Ojasalu K; Brehm C; Hartung K; Nischak M; Finkernagel F; Rexin P; Nist A; Pavlakis E; Stiewe T; Jansen JM; Wagner U; Gattenlöhner S; Bräuninger A; Müller-Brüsselbach S; Reinartz S; Müller R
Mol Oncol; 2020 Sep; 14(9):2142-2162. PubMed ID: 32533757
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.
Latifi A; Luwor RB; Bilandzic M; Nazaretian S; Stenvers K; Pyman J; Zhu H; Thompson EW; Quinn MA; Findlay JK; Ahmed N
PLoS One; 2012; 7(10):e46858. PubMed ID: 23056490
[TBL] [Abstract][Full Text] [Related]
5. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
6. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
[TBL] [Abstract][Full Text] [Related]
7. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
[TBL] [Abstract][Full Text] [Related]
8. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
[TBL] [Abstract][Full Text] [Related]
9. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
[TBL] [Abstract][Full Text] [Related]
10. Spheroid architecture strongly enhances miR-221/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression.
Ward AS; Hall CN; Tree MO; Kohtz DS
Mol Biol Rep; 2024 Feb; 51(1):275. PubMed ID: 38310615
[TBL] [Abstract][Full Text] [Related]
11. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
[TBL] [Abstract][Full Text] [Related]
12. Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer.
Velletri T; Villa CE; Cilli D; Barzaghi B; Lo Riso P; Lupia M; Luongo R; López-Tobón A; De Simone M; Bonnal RJP; Marelli L; Piccolo S; Colombo N; Pagani M; Cavallaro U; Minucci S; Testa G
Cell Death Differ; 2022 Mar; 29(3):614-626. PubMed ID: 34845371
[TBL] [Abstract][Full Text] [Related]
13. Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.
Wintzell M; Hjerpe E; Åvall Lundqvist E; Shoshan M
BMC Cancer; 2012 Aug; 12():359. PubMed ID: 22901285
[TBL] [Abstract][Full Text] [Related]
14. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
15. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer.
Al Habyan S; Kalos C; Szymborski J; McCaffrey L
Oncogene; 2018 Sep; 37(37):5127-5135. PubMed ID: 29789717
[TBL] [Abstract][Full Text] [Related]
16. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
[TBL] [Abstract][Full Text] [Related]
17. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
18. Engineered 3D Model of Cancer Stem Cell Enrichment and Chemoresistance.
Ward Rashidi MR; Mehta P; Bregenzer M; Raghavan S; Fleck EM; Horst EN; Harissa Z; Ravikumar V; Brady S; Bild A; Rao A; Buckanovich RJ; Mehta G
Neoplasia; 2019 Aug; 21(8):822-836. PubMed ID: 31299607
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites.
Kim S; Kim S; Kim J; Kim B; Kim SI; Kim MA; Kwon S; Song YS
Sci Rep; 2018 Aug; 8(1):12724. PubMed ID: 30143682
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer.
Long L; Hu Y; Long T; Lu X; Tuo Y; Li Y; Ke Z
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34969774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
